Retraction: Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study (Journal of Clinical Psychopharmacology (2008) 28 (39-44) DOI: 10.1097/jcp.0b013e31816073a5);Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: A double-blind, placebo-controlled and randomized study

Journal of Clinical Psychopharmacology

Volumn 28, Issue 1, 2008, Pages 39-44

  Safarinejad, Mohammad Reza ^a,b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; PINDOLOL;

ADULT; ANEJACULATION; ARTICLE; CLINICAL TRIAL; COITUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EJACULATION DISORDER; ELECTROCARDIOGRAM; HEADACHE; HUMAN; INCIDENCE; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTRAVAGINAL EJACULATORY LATENCY TIME; MAJOR CLINICAL STUDY; MALE; MEARES STARNEY TEST; NAUSEA; PREMATURE EJACULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SIDE EFFECT; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; VITAL SIGN; WEIGHT CHANGE; XEROSTOMIA;

EID: 38349101302     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000001540     Document Type: Erratum

References (20)

1. Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep. 2000;2:189-195.
2. Bennett D. Treatment of ejaculatio praecox with monoamine oxidase inhibitors [letter]. Lancet. 1961;2:1309.
3. Waldinger MD, Zwinderman AH, Schweitzer DH, et al. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res. 2004;16:369-381.
4. Roblin D. Premature ejaculation: diagnosis and pharmacotherapy. Int J Pharm Med. 2000;14:313-318.
5. Giuliano F, Clement P. Serotonin and premature ejaculation: from physiology to patient management. Eur Urol. 2006;50:454-466.
6. Waldinger MD, Rietschel M, Nothen MM, et al. Familial occurrence of primary premature ejaculation. Psychiatr Genet. 1998;8:37-40.
7. Hillegaart V, Ahlenius S. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181. Br J Pharmacol. 1998;125:1733-1174.
8. Norden MJ. Buspirone treatment of sexual dysfunction associated with SSRI. Depression. 1994;2:109-112.
9. Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol. 1995;15:217-222.
10. Invernizzi R, Belli S, Samanin R. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 1992;584:322-324.
11. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 1994;15:220-226.
12. Blier P, Bergeron R, de Montigny C. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response. Neuropsychopharmacology. 1997;16:333-338.
13. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Interview for DSM-III-R. (SCID). New York: New York State Psychiatric Institute of Biometrics Research; 1987.
14. Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822-830.
15. Kim SW, Paick JS. Short-term analysis of the effects of as needed use of sertraline at 5 pm for the treatment of premature ejaculation. Urology. 1999;54:544-547.
16. Perez V, Puigdemont D, Gilaberte I, et al. Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical pharmacokinetic, and methodological factors. J Clin Psychopharmacol. 2001;21:36-45.
17. Moreland AJ, Makela EH. Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation. Ann Pharmacother. 2005;39:1296-1301.
18. Richardson D, Green J, Ritcheson A, et al. A review of controlled trials in the pharmacological treatment of premature ejaculation. Int J STD AIDS. 2005;16:651-658.
19. Safarinejad MR, Hosseini SY. Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol. 2006;26:27-31.
20. Salem EA, Wilson SK, Bissada NK, et al. Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med. 2007 March 14. [Epub ahead of print].